8-K: Maquia Capital Faces Delisting Threat from Nasdaq Due to Late Filing and SPAC Rule Violation

Maquia Capital Acquisition Corporation is facing potential delisting from the Nasdaq Stock Market due to a late financial filing and failure to complete a business combination within the required timeframe.

Summary

• Maquia Capital Acquisition Corporation received a delisting notice from Nasdaq on May 22, 2024, due to the company's failure to file its Form 10Q report for the period ending March 31, 2024.
• This delisting notice is a result of the company not complying with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of periodic financial reports.
• Maquia intends to appeal the notice and request a hearing, which will temporarily stay the suspension of its securities for 15 days.
• The company is working to file the delinquent report as soon as possible to regain compliance.
• Previously, on May 7, 2024, Maquia received a notice for not complying with Nasdaq Listing Rule IM-5101-2, which requires a SPAC to complete a business combination within 36 months of its IPO.
• The company has also appealed this determination, with a hearing set for June 20, 2024.
• Additionally, Maquia failed to hold its annual meeting within the required timeframe, but has since held the meeting on May 20, 2024, and is now in compliance with that rule.

Sentiment

Score: 2

Explanation: The sentiment is negative due to the delisting notice, failure to meet multiple listing requirements, and uncertainty about regaining compliance.

Positives

• Maquia intends to appeal the delisting notice and request a hearing, which will temporarily stay the suspension of its securities.
• The company is working to file the delinquent report as soon as possible to regain compliance.
• Maquia has held its annual meeting on May 20, 2024, and is now in compliance with that rule.

Negatives

• Maquia received a delisting notice from Nasdaq due to a late filing of its Form 10Q report.
• The company is not in compliance with Nasdaq Listing Rule 5250(c)(1).
• Maquia also received a notice for not completing a business combination within the required timeframe.
• There is no assurance that Nasdaq will accept the company's plan to regain compliance.

Risks

• There is a risk that Nasdaq may not accept Maquia's plan to regain compliance.
• The company may not be successful in implementing its plan to regain compliance.
• The company's securities could be delisted from the Nasdaq Stock Market.
• The company has failed to meet multiple Nasdaq listing requirements.

Future Outlook

The company intends to submit a plan to regain compliance with Nasdaq listing requirements and file an appeal within the required timeframe, but there is no guarantee of success.

Management Comments

• The Company intends to timely appeal the notice and request a hearing.
• The Company is working diligently to file the delinquent periodic report as soon as possible to regain full compliance with the Listing Rule.

Industry Context

This announcement highlights the challenges faced by SPACs in meeting deadlines for business combinations and maintaining compliance with listing requirements, a common issue in the current market environment.

Comparison to Industry Standards

• Many SPACs have struggled to complete mergers within the 36-month timeframe, leading to delisting notices, similar to Maquia's situation.
• The failure to file timely financial reports is a serious breach of listing rules, and companies like Maquia are often subject to delisting procedures.
• Other SPACs such as Gores Metropoulos II, and Churchill Capital Corp IV have faced similar challenges with deadlines and compliance.

Stakeholder Impact

• Shareholders face the risk of losing their investment if the company is delisted.
• The company's reputation and credibility are negatively impacted by the delisting notice.
• Employees may experience uncertainty about the company's future.

Next Steps

• Maquia intends to appeal the delisting notice and request a hearing.
• The company will work to file the delinquent Form 10Q report as soon as possible.
• The company will attend a hearing on June 20, 2024, regarding the business combination rule violation.

Key Dates

Keywords

delisting, Nasdaq, Form 10Q, compliance, SPAC, business combination, listing rule, appeal, hearing, financial report